Physician profile
Adele I Clay
NPI 1881670933
$3,383.96
in general payments reported to CMS, 2019-2025
41 companies · $637 in 2025
The $637 reported for 2025 was more than what 90% of Obstetrics & Gynecology (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $257 · 2022: $739 · 2023: $945 · 2024: $806 · 2025: $637.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,387.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $385.27 | 2022-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $365.63 | 2021-2025 | Slynd |
| Agile Therapeutics, INC. | $309.01 | 2021-2024 | Twirla |
| Sumitomo Pharma America, INC. | $259.44 | 2023-2025 | Myfembree, Gemtesa |
| Abbvie INC. | $251.11 | 2021-2024 | |
| Coopersurgical, INC. | $139.38 | 2022-2025 | Paragard T 380a, Paragard T 380a |
| Mayne Pharma Commercial LLC | $123.94 | 2022-2024 | |
| Exact Sciences Corporation | $123.16 | 2023-2025 | Cologuard Collection Kit |
| Millicent US INC | $118.87 | 2025 | Femlyv, Intrarosa, Femring |
| Myovant Sciences INC. | $114.48 | 2021-2022 | |
| Daiichi Sankyo INC. | $98.65 | 2023-2025 | Injectafer |
| Sage Therapeutics, LLC | $97.54 | 2024-2025 | Zurzuvae |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $89.75 | 2022-2025 | Xifaxan |
| Merck Sharp & Dohme LLC | $84.95 | 2023-2024 | Gardasil 9, Gardasil |
| Pfizer INC. | $77.96 | 2021-2024 |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adele Clay listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.